2m 2m 2m 2m 2m 2m 2m
AbbVie (ABBV)
NYSE
$297.40+$2.42 (+0.82%)
Price as of Nov 12, 2026 8:20 AM EST- $521.4BMarket Cap
- 30.26%1-Year Change
- Drug Manufacturers - GeneralIndustry
AbbVie (ABBV)
$297.40+$2.42 (+0.82%)
ABBV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $294.98 | ||
Change | +$1.09 (+0.37%) | ||
Open | $291.36 | ||
High | $295.46 | ||
Low | $289.73 | ||
Previous Close | $293.89 | ||
Volume | 3,262,127 | ||
30-Day Average Volume | 5,488,935 | ||
1-Week Change | 0.05% | ||
1-Month Change | 7.35% | ||
1-Year Change | 30.26% | ||
3-Year Change | 135.17% | ||
5-Year Change | 202.07% | ||
Fundamentals | |||
Shares Outstanding | 1.8B | ||
Total Assets | $147.7B | ||
Market Cap | $521.4B | ||
Enterprise Value | $591.5B | ||
Period: QTR TTM FY | |||
Revenue | $17.4B | ||
Net Income | $4.2B | ||
Free Cash Flow | $7.3B | ||
EBIT | $5.5B | ||
EBITDA | $7.2B | ||
Net Working Capital | -$5.6B | ||
EPS | $2.37 | ||
Enterprise Value/EBITDA | 82 | ||
Enterprise Value/Revenue | 34 | ||
P/B | -114 | ||
P/E | 124 | ||
PEG | 7 | ||
Price/Free Cash Flow | 71 | ||
Price/Operating Cash Flow | 69 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.35% | ||
Trailing Annual Dividend Yield | 2.35% | ||
Ex-Dividend Date | 01/15/2027 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield